Roivant Sciences Ltd. (ROIV) Tops Q2 EPS by 15c
Tweet
Share
E-mail
Get Alerts ROIV Hot Sheet
Join SI Premium – FREE
Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.17), $0.15 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $1.57 million versus the consensus estimate of $5.6 million.
For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi downgrades Abercrombie & Fitch to neutral after 36% stock surge
- Lantronix (LTRX) Reports In-Line Q4 EPS; Offers Guidance
- J.M. Smucker (SJM) PT Raised to $132 at Stifel
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
